Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects
2008-003871-32Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Audenz in Influenza A infection (3 arms), sponsored by Novartis. Primary endpoints: Safety endpoints and Immunogenicity endpoints. Started Jul 2008; status: completed.
02
Drugs
Audenz
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on 2008-003871-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003871-32.